Caring for Caregivers’ Well-Being in Gynecologic Cancers With Abigail Zamorano, MD

The Unique Burden of Caregiving

“Caregivers are vital to allowing a patient to proceed through their treatment the best they can, because they take on a lot of the responsibilities that the patient had,” Dr. Zamorano explained. Caregivers shoulder a complex array of responsibilities, from providing transportation to frequent appointments, managing medications, monitoring symptoms, and often taking on additional household and financial duties. For many, these tasks are layered atop existing caregiving roles for children or elderly relatives, amplifying the strain.

Distinctive Challenges in Gynecologic Oncology

Gynecologic cancers introduce unique social and emotional stressors. The stigma and discomfort surrounding these diagnoses can make open communication difficult, not only for patients but also for their caregivers. “A lot of patients and caregivers hesitate to talk openly about gynecologic cancers, because it’s still a topic that many people don’t feel comfortable speaking about,” Dr. Zamorano noted. Additionally, in contrast to other diseases where caregivers are predominantly female, many caregivers in gynecologic oncology are male spouses, shifting traditional caregiving dynamics.

Study Design and Key Findings

Dr. Zamorano’s team conducted a prospective cohort study, surveying both patients and their self-identified caregivers at the start of chemotherapy and again three months later. Distress was measured using the Modified Caregiver Strain Index (MCSI) and social determinants of health (SDOH) metrics, with striking findings revealed:

• Demographic insights: The study highlighted that a significant portion of caregivers were male spouses, which differs from other chronic illnesses where caregivers are predominantly female. Additionally, a substantial percentage of caregivers were Hispanic, lived with the patient, cared for others, or worked full time, adding layers of complexity to their caregiving responsibilities.
• Increased caregiver distress: The study found a significant increase in caregiver distress over the three-month period. At the initiation of chemotherapy, 42% of caregivers were measured as having high distress or strain, and this proportion increased to 66% after three months.
• Stable patient distress: In contrast to the caregivers, patient distress remained relatively stable or showed a slight decrease during the same period. This suggests that while patients’ needs were being addressed, caregivers’ needs were not adequately met.
• Worsening social determinants of health (SDOH): The SDOH risk factors for caregivers increased from 63% at the start of chemotherapy to 87% after three months. This indicates that the burden of caregiving negatively impacted caregivers’ access to essential resources such as food, transportation, and housing.

“What I thought was most interesting was that we saw caregiver distress go up, while patient distress stayed about the same or had a slight decrease,” Dr. Zamorano underscored. “This tells me that either we are appropriately addressing patient distress as they go through chemotherapy, and we’re potentially not doing that for caregivers, or the patients are accepting everything as they’re going through chemotherapy, and the caregivers are bottling it up. This difference was very striking to us, and it tells us that there’s a lot more work to do to address the needs of caregivers in this patient population.”

How Clinicians Can Help Support Caregivers

Dr. Zamorano urges clinicians to proactively identify and engage caregivers, ask about their needs, and connect them with resources for transportation, food, housing, and psychological support. “I think acknowledging caregivers’ existence and acknowledging the hard work that they’re doing is critical and will offset some of the strain that they’re feeling,” she explained. She and her team are now working on personalized navigation tools to better support caregivers, aiming to reduce distress and improve outcomes for both patients and their support networks.

Conclusion

Dr. Zamorano emphasized the importance of recognizing and appreciating the vital role that caregivers play. By acknowledging their hard work and inquiring about their well-being, clinicians can significantly improve the lives of both patients and their caregivers.

“Something that has struck me throughout this process as I’ve presented our findings is the number of patients and caregivers who have come up to us and thanked us for looking into caregiver distress,” Dr. Zamorano said. “This is a part of gynecologic cancer research that hasn’t really been explored to its full extent. Caregivers really appreciate being asked how they’re doing, and I think that as more of us take that on, the lives of our patients and caregivers will be vastly improved.”

Key Takeaways

• Caregiver distress increases significantly during the first three months of chemotherapy for gynecologic cancers.
• Social determinants of health play a major role in caregiver strain.
• Caregivers, especially in gynecologic oncology, face unique social and emotional challenges.
• Clinicians should routinely identify who their patients’ caregivers are, assess their needs, and provide targeted support and resources.
• Acknowledging and supporting caregivers can greatly improve their well-being.

About Dr. Zamorano

Abigail Zamorano, MD, is an Assistant Professor of Gynecologic Oncology in McGovern Medical School at UT Health Houston. She specializes in the treatment of gynecologic malignancies, with a focus on clinical trials, global health, caregiver support, and disparities in screening, diagnosis, treatment, and outcomes. Dr. Zamorano serves on several boards and committees in gynecologic cancers, and she also serves as Director of the Houston PAP Project, which provides free cervical cancer screenings.